Allergan includes cryolipolysis research in its AMWC 2026 program
Source publication date
Site published
The March 26 release names controlled-cooling molecular research and a patient survey with a supporting case report. It discusses CoolSculpting alongside medical-weight-loss aesthetics. Hardware models are unspecified. Separately, FDA K233732 identifies CoolSculpting Elite: specified body sites have a BMI limit of 30; submental/submandibular treatment allows up to 46.2.
Summary
Two announced body-contouring posters address adipose biology and patient demand.
Editorial view
Editorial view: relevant to aesthetic follow-up after weight loss, with endpoints kept separate.
Evidence and limitations
Conference summaries are not full controlled efficacy evidence or a new clearance. Do not attribute unspecified posters specifically to Elite. These devices address local fat contours, not obesity or weight loss. Paradoxical adipose enlargement may require surgery.